01 · Process stage
PlannedMaterial component assessment
Evaluate the proposed syringe barrel and closure components against the planned equipment interfaces.
Capabilities · Sterile products & aseptic filling
Prefilled syringes
A proposed service scope for prefilled syringe presentations, connecting syringe handling, drug product filling, plunger placement and inspection.
PlannedCatalogue scope
Service statusPlanned
Planned.
Technical boundaries and readiness need confirmation before an activity could be presented as available.
Basis · Catalogue scope
- Status
- PlannedNo available service asserted
- Source-plan relationship
- Catalogue scopeProposed catalogue expansion
- Readiness
- Not establishedProduct and process evidence needed
- Facility roadmap
- First commercial batch target Q1 2028 · indicativeNot a service date
01 · Proposed service scope
Start with the product and its container.
Prefilled syringe filling is presented as a planned service domain. The precise drug product, primary container presentation and proposed technical route would define its actual scope.
The initial Boten plan identifies vial, ampoule and cartridge formats. Prefilled syringes sit outside this initial plan, so their inclusion in the catalogue requires separate scope confirmation before a service could exist.
Syringe dimensions and closure mechanics define the processing boundary. Any expectation of assembling needle-safety guards or auto-injectors would necessitate distinct technical discussions independent of the primary liquid filling steps.
Catalogue boundary
A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.
02 · Presentation families
Match the route to the format.
| Format | Planning note | Basis | Status |
|---|---|---|---|
| Glass syringes | Standard presentations proposed for evaluation against potential processing limitations. | Catalogue scope | Planned |
| Polymer syringes | Polymeric containers require separate compatibility and complex processing assessments. | Catalogue scope | Planned |
| Biologic preparationsBiological drug-substance development | Biological products often require specialised pump mechanisms and handling. | Catalogue scope | Planned |
03 · Process scope for discussion
Make the sequence and its evidence visible.
02 · Process stage
PlannedFormulation suitability
Determine how the liquid product would interact with the dosing system and container.
03 · Process stage
PlannedHandling pathways
Review the proposed mechanisms for transferring sterile components into the critical processing zone.
04 · Process stage
PlannedDosing controls
Establish target fill volumes, pump compatibility and environmental protections during liquid transfer.
05 · Process stage
PlannedPlunger placement
Define the vacuum or mechanical placement techniques required to seat the closure effectively.
06 · Process stage
PlannedVisual inspection
Identify criteria for assessing particulates, closure integrity and fill volume anomalies during evaluation.
Illustrative sequence
This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.
04 · Supporting services
No service stands alone.
01PlannedCatalogue scope
Combination products & injector devices
Drug-device interfaces, assembly and presentation-specific verification.
Explore proposed scope02PlannedCatalogue scope
Container-closure integrity testing
Presentation-specific integrity questions and the supporting method.
Explore proposed scope03PlannedCatalogue scope
Secondary packaging
Cartoning, labelling, leaflet insertion and pack configuration.
Explore proposed scope05 · Readiness questions
A service claim needs a defined evidence base.
- Syringe specifications
- Exact dimensional tolerances, material compositions and supplier preparation conditions.
- Qualification status
- Appropriate technical qualification of any future syringe handling lines.
- Simulation data
- Media fill data demonstrating the ability to maintain sterile conditions.
- Closure evidence
- Data showing the chosen plunger maintains the required sterility boundary.
- Regulatory authorisations
- Permissions from the applicable authority for syringe manufacturing activities.
- Quality boundaries
- Documented agreements covering defect investigation and product release duties.
06 · Practical questions
Before a technical discussion.
Is this service currently available?
No. The service is Planned. This page is a scope proposal and does not establish an operating filling service.
Which formats are in scope?
The proposal covers standard glass and polymer formats. Any specific presentation would require evaluating existing project plans for equipment integration.
What information helps define the question?
Identify the proposed formulation, container dimensions, development stage, destination and the technical question. Confidential data should only be shared through an agreed route.
Is there a service launch quarter?
No. No service-specific quarter is established. Project-wide indicative milestones do not commit any individual service to a start date.
Does a technical discussion establish supply?
No. Feasibility, equipment scope, material permissions, evidence and a technical agreement would need to be established before any supply commitment.
Professional enquiries
Discuss a defined question.
Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.